Clinical Cancer Research, Vol 3, Issue 4 619-625, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Clinical implications of telomerase activity levels in acute leukemia

JH Ohyashiki, K Ohyashiki, H Iwama, S Hayashi, K Toyama and JW Shay
First Department of Internal Medicine, Tokyo Medical College, 6-7-1 Nishi-shinjuku, Shinjuku-ju, Tokyo 160, Japan.

In the present study, we used the telomeric repeat amplification protocol assay, an internal telomerase assay standard, and an automatic DNA sequencer to detect and quantitate telomerase activity in blood samples obtained from normal and acute leukemia patients. Telomerase activity was analyzed in 78 acute leukemia patients and ranged from 0.65 to 147 relative to the internal standard. Compared to the age-matched normal levels of telomerase activity in the peripheral blood cells, we determined that 45 (81.8%) of 55 acute myeloid leukemia (AML) and 16 (69.6%) of 23 acute lymphoid leukemia patients had elevated telomerase activity. There was no relationship between peak telomere length and telomerase activity in both acute lymphoid leukemia and AML patients. In AML, the level of telomerase activity was associated with French-American-British subtypes and cytogenetics, and patients with elevated telomerase activity had high leukocyte counts and more frequent extramedullary involvement during the disease. Among 78 patients, 5 had high levels of telomerase activities similar to immortalized leukemia cell lines; these 5 patients had a very poor prognosis (P < 0.05). The levels of telomerase activity significantly decreased in patients in complete remission. Most of the patients in complete remission showed a normal level of telomerase activity; however, two of them had low to moderate telomerase activity, and they relapsed shortly after entering complete remission. In relapsed patients, there is a general trend for increased telomerase levels, and 2 of the 13 patients retained high telomerase activity, whereas the other 11 had normal to moderate telomerase activity. These results suggest that telomerase activity may be a useful additional method for monitoring the disease condition in acute leukemia patients.

This article has been cited by other articles:

				M. W. Drummond, S. Balabanov, T. L. Holyoake, and T. H. Brummendorf Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells Stem Cells, August 1, 2007; 25(8): 1853 - 1861. [Abstract] [Full Text] [PDF]

				J. C. Y. Wang, J. K. Warner, N. Erdmann, P. M. Lansdorp, L. Harrington, and J. E. Dick Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells PNAS, October 4, 2005; 102(40): 14398 - 14403. [Abstract] [Full Text] [PDF]

				A. M. Ferraris, R. Mangerini, N. Pujic, O. Racchi, D. Rapezzi, A. Gallamini, S. Casciaro, and G. F. Gaetani High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia Blood, March 1, 2005; 105(5): 2138 - 2140. [Abstract] [Full Text] [PDF]

				J. Arai, M. Yasukawa, H. Ohminami, M. Kakimoto, A. Hasegawa, and S. Fujita Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes Blood, May 1, 2001; 97(9): 2903 - 2907. [Abstract] [Full Text] [PDF]

				J. W. Shay, Y. Zou, E. Hiyama, and W. E. Wright Telomerase and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 677 - 685. [Abstract] [Full Text] [PDF]

				M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture Cancer Res., February 1, 2000; 60(3): 610 - 617. [Abstract] [Full Text]

				B.-S. Herbert, A. E. Pitts, S. I. Baker, S. E. Hamilton, W. E. Wright, J. W. Shay, and D. R. Corey Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death PNAS, December 7, 1999; 96(25): 14276 - 14281. [Abstract] [Full Text] [PDF]

				J. H. Ohyashiki, H. Iwama, N. Yahata, K. Ando, S. Hayashi, J. W. Shay, and K. Ohyashiki Telomere Stability Is Frequently Impaired in High-Risk Groups of Patients with Myelodysplastic Syndromes Clin. Cancer Res., May 1, 1999; 5(5): 1155 - 1160. [Abstract] [Full Text] [PDF]